• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Extended blood collection period required to define distribution and elimination kinetics of propofol.确定丙泊酚的分布和消除动力学需要延长采血时间。
Br J Clin Pharmacol. 1988 Aug;26(2):187-90. doi: 10.1111/j.1365-2125.1988.tb03386.x.
2
Pharmacokinetics and protein binding of propofol in patients with cirrhosis.丙泊酚在肝硬化患者中的药代动力学及蛋白结合情况
Anesthesiology. 1988 Dec;69(6):887-91. doi: 10.1097/00000542-198812000-00014.
3
[The course of blood concentrations of propofol administered at a constant rate, combined with fentanyl].[以恒定速率输注丙泊酚并联合芬太尼时的血药浓度变化过程]
Ann Fr Anesth Reanim. 1988;7(5):377-82. doi: 10.1016/s0750-7658(88)80053-4.
4
[Pharmacokinetics of propofol as an induction agents in adults].[丙泊酚作为成人诱导麻醉剂的药代动力学]
Cah Anesthesiol. 1987 Oct;35(6):427-8.
5
Pharmacokinetics of propofol in female patients. Studies using single bolus injections.丙泊酚在女性患者中的药代动力学。采用单次推注注射的研究。
Br J Anaesth. 1987 Sep;59(9):1103-10. doi: 10.1093/bja/59.9.1103.
6
Pharmacokinetics and pharmacodynamics of propofol infusions during general anesthesia.全身麻醉期间丙泊酚输注的药代动力学和药效学
Anesthesiology. 1988 Sep;69(3):348-56. doi: 10.1097/00000542-198809000-00011.
7
Pharmacokinetics of propofol administered by continuous infusion in patients with cirrhosis. Preliminary results.丙泊酚持续输注在肝硬化患者中的药代动力学。初步结果。
Anaesthesia. 1988 Mar;43 Suppl:23-4. doi: 10.1111/j.1365-2044.1988.tb09063.x.
8
Pharmacokinetics of propofol when given by intravenous infusion.静脉输注丙泊酚的药代动力学。
Br J Clin Pharmacol. 1990 Jul;30(1):144-8. doi: 10.1111/j.1365-2125.1990.tb03755.x.
9
Pharmacokinetics in laboratory animals of ICI 35 868, a new i.v. anaesthetic agent.新型静脉麻醉剂ICI 35868在实验动物体内的药代动力学
Br J Anaesth. 1980 Aug;52(8):743-6. doi: 10.1093/bja/52.8.743.
10
Pharmacokinetics of propofol (diprivan) in elderly patients.老年患者中丙泊酚(得普利麻)的药代动力学
Br J Anaesth. 1988 Feb;60(2):146-50. doi: 10.1093/bja/60.2.146.

引用本文的文献

1
Safety of Propofol When Used for Rapid Sequence Intubation in Septic Patients: A Multicenter Cohort Study.丙泊酚用于脓毒症患者快速顺序诱导插管的安全性:一项多中心队列研究。
Hosp Pharm. 2022 Apr;57(2):287-293. doi: 10.1177/00185787211029547. Epub 2021 Jul 8.
2
The Effects of Propofol and Sevoflurane on Postoperative Delirium in Older Patients: A Randomized Clinical Trial Study.丙泊酚和七氟醚对老年患者术后谵妄的影响:一项随机临床试验研究。
J Alzheimers Dis. 2020;76(4):1627-1636. doi: 10.3233/JAD-200322.
3
Population pharmacokinetics of intravenous sufentanil in critically ill patients supported with extracorporeal membrane oxygenation therapy.接受体外膜肺氧合治疗的危重症患者静脉注射舒芬太尼的群体药代动力学。
Crit Care. 2019 Jul 9;23(1):248. doi: 10.1186/s13054-019-2508-4.
4
The use of PBPK modeling across the pediatric age range using propofol as a case.以丙泊酚为例,在儿科年龄范围内使用 PBPK 模型。
J Pharmacokinet Pharmacodyn. 2018 Dec;45(6):765-785. doi: 10.1007/s10928-018-9607-8. Epub 2018 Oct 8.
5
First administration to man of Org 25435, an intravenous anaesthetic: A Phase 1 Clinical Trial.首次给人体静脉注射 Org 25435 麻醉剂:一项 I 期临床试验。
BMC Anesthesiol. 2010 Jun 29;10:10. doi: 10.1186/1471-2253-10-10.
6
A case of propofol-induced delayed-onset refractory myoclonic seizures.一例丙泊酚诱导的迟发性难治性肌阵挛性癫痫发作。
J Clin Neurol. 2007 Sep;3(3):154-7. doi: 10.3988/jcn.2007.3.3.154. Epub 2007 Sep 20.
7
Human physiologically based pharmacokinetic model for propofol.丙泊酚的人体生理药代动力学模型。
BMC Anesthesiol. 2005 Apr 22;5(1):4. doi: 10.1186/1471-2253-5-4.
8
Pharmacokinetics, induction of anaesthesia and safety characteristics of propofol 6% SAZN vs propofol 1% SAZN and Diprivan-10 after bolus injection.单次注射后,6% SAZN丙泊酚与1% SAZN丙泊酚及得普利麻-10的药代动力学、麻醉诱导及安全性特征
Br J Clin Pharmacol. 1999 Jun;47(6):653-60. doi: 10.1046/j.1365-2125.1999.00942.x.
9
Propofol. An update of its use in anaesthesia and conscious sedation.丙泊酚。其在麻醉和清醒镇静中应用的最新情况。
Drugs. 1995 Sep;50(3):513-59. doi: 10.2165/00003495-199550030-00008.
10
Propofol in patients with cardiac disease.患有心脏病的患者使用丙泊酚的情况。
Can J Anaesth. 1993 Aug;40(8):730-47. doi: 10.1007/BF03009770.

本文引用的文献

1
Blood disoprofol levels in anesthetised patients. Correlation of concentrations after single or repeated doses with hypnotic activity.麻醉患者的血中丙泊酚水平。单次或重复给药后浓度与催眠活性的相关性。
Anaesthesia. 1982 May;37(5):536-40. doi: 10.1111/j.1365-2044.1982.tb01223.x.
2
The role of metabolism and protein binding in thiopental anesthesia.代谢及蛋白质结合在硫喷妥钠麻醉中的作用
Anesthesiology. 1983 Feb;58(2):146-52. doi: 10.1097/00000542-198302000-00008.
3
Improved method for the determination of propofol in blood by high-performance liquid chromatography with fluorescence detection.高效液相色谱荧光检测法测定血液中丙泊酚的改进方法
J Chromatogr. 1987 Oct 9;421(1):171-6. doi: 10.1016/0378-4347(87)80394-8.
4
Pharmacokinetics of propofol in female patients. Studies using single bolus injections.丙泊酚在女性患者中的药代动力学。采用单次推注注射的研究。
Br J Anaesth. 1987 Sep;59(9):1103-10. doi: 10.1093/bja/59.9.1103.
5
High-performance liquid chromatographic determination and preliminary pharmacokinetics of propofol and its metabolites in human plasma and urine.高效液相色谱法测定人血浆和尿液中丙泊酚及其代谢产物并进行初步药代动力学研究
J Chromatogr. 1987 Jul 3;417(2):458-64. doi: 10.1016/0378-4347(87)80145-7.
6
Disposition of propofol in patients undergoing surgery. A comparison in men and women.接受手术患者中丙泊酚的处置。男性与女性的比较。
Br J Anaesth. 1986 Oct;58(10):1075-9. doi: 10.1093/bja/58.10.1075.
7
Curve fitting and modeling in pharmacokinetics and some practical experiences with NONLIN and a new program FUNFIT.药代动力学中的曲线拟合与建模以及使用NONLIN和新程序FUNFIT的一些实践经验。
J Pharmacokinet Biopharm. 1977 Oct;5(5):513-31. doi: 10.1007/BF01061732.

确定丙泊酚的分布和消除动力学需要延长采血时间。

Extended blood collection period required to define distribution and elimination kinetics of propofol.

作者信息

Campbell G A, Morgan D J, Kumar K, Crankshaw D P

机构信息

Department of Surgery, Royal Melbourne Hospital, University of Melbourne, Parkville, Victoria, Australia.

出版信息

Br J Clin Pharmacol. 1988 Aug;26(2):187-90. doi: 10.1111/j.1365-2125.1988.tb03386.x.

DOI:10.1111/j.1365-2125.1988.tb03386.x
PMID:3264711
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1386527/
Abstract

The pharmacokinetics of propofol were investigated following bolus intravenous administration of 2-3 mg kg-1 of drug to eight surgical patients. Apparent elimination half-life, volume of distribution and systemic blood clearance of propofol correlated strongly with the sampling period, which ranged from 8 to 52 h, depending on the time taken for the propofol concentration to reach the detection limit of the assay. In the three patients in whom the sampling period exceeded 42 h, apparent elimination half-life (55.6 h) and apparent volume of distribution (1370 l) greatly exceeded previously published estimates and systemic blood clearance (1020 ml min-1) was much less than previous estimates. This suggests that previous estimates were biased by the relatively short duration of blood collection in those studies (8 to 12 h).

摘要

在对8名外科手术患者静脉推注2 - 3 mg/kg的丙泊酚后,研究了丙泊酚的药代动力学。丙泊酚的表观消除半衰期、分布容积和全身血药清除率与采样期密切相关,采样期为8至52小时,这取决于丙泊酚浓度达到检测限所需的时间。在3名采样期超过42小时的患者中,表观消除半衰期(55.6小时)和表观分布容积(1370升)大大超过先前公布的估计值,全身血药清除率(1020毫升/分钟)远低于先前估计值。这表明先前的估计值受到那些研究中相对较短的采血时间(8至12小时)的影响而存在偏差。